Oncoclinicas do Brasil (ONCO3) — Capital Reinvestment Ratio
Oncoclinicas do Brasil (ONCO3) has a Capital Reinvestment Ratio of 0.35x as of September 2025, meaning it reinvests 0% of its operating cash flow (R$151.75 Million) in capital expenditures (R$52.99 Million). See Oncoclinicas do Brasil (ONCO3) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Oncoclinicas do Brasil Capital Reinvestment Ratio (2013–2020)
This chart tracks Oncoclinicas do Brasil's Capital Reinvestment Ratio across 6 annual periods. Check how aggressively does Oncoclinicas do Brasil reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Oncoclinicas do Brasil (2013–2020)
Year-by-year Capital Reinvestment Ratio for Oncoclinicas do Brasil from 2013 to 2020. For live market cap and broader valuation context, see Oncoclinicas do Brasil (ONCO3) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (BRL) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 2.10x | R$97.56 Million | R$204.80 Million | ▲ +7.1% |
| 2019 | 1.96x | R$97.08 Million | R$190.19 Million | ▼ -68.1% |
| 2018 | 6.14x | R$38.86 Million | R$238.45 Million | ▲ +2296.1% |
| 2017 | 0.26x | R$135.26 Million | R$34.64 Million | ▼ -83.7% |
| 2014 | 1.57x | R$9.29 Million | R$14.57 Million | ▼ -30.5% |
| 2013 | 2.26x | R$7.34 Million | R$16.58 Million | — |